Click and hold a term momentarily to select items without that term.
79 items
- HumanBetaCellLinesPKBSM6556DJTOEndoC-βH1 cell line, treated with 50 U/mL Interleukin-1 beta for 86400 secondsA Data and Administrative Coordinating Center for the PanKbase Consortiumreleased
- HumanBetaCellLinesPKBSM3533XIDSEndoC-βH1 cell line, treated with 0 μM HEK293A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM9187LZBVEndoC-βH1 cell line, treated with 0 μM lentiCRISPRv2A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM2973NJDCEndoC-βH1 cell line, treated with 0 μM NLRC5 for 8 hours, 2000 U/mL Interferon alpha for 8 hoursA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM6845SNYEEndoC-bH2 cell line, treated with 35 mM Glucose for 72 hoursA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM0561GQKPEndoC-bH3 cell line, treated with 1 mM 4-hydroxy tamoxifen for 21 daysA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM5212UTHGEndoC-βH1 cell line, treated with 1000 U/mL Tumor necrosis factor for 86400 secondsA Data and Administrative Coordinating Center for the PanKbase Consortiumreleased
- HumanBetaCellLinesPKBSM6750EOBQEndoC-βH1 cell line, treated with 0 μM SRRM3A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM5416TOEIEndoC-βH1 cell line, treated with 0 μM METTL14A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM0734OIDUEndoC-βH1 cell line, treated with 2 μM dexamethasone for 86400 secondsA Data and Administrative Coordinating Center for the PanKbase Consortiumreleased
- HumanBetaCellLinesPKBSM8133OGIJEndoC-βH1 cell line, treated with 0 μM negative control siRNAA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM8660JQFDEndoC-βH1 cell line, treated with 0 μM negative control siRNAA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM6207TNSYEndoC-βH1 cell line, treated with 0 μM SIX2A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM2550NVQOEndoC-βH1 cell line, treated with 0 μM TNFA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM4462KSYCEndoC-βH1 cell line, treated with 0 μM SIX3A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM8514OGUPEndoC-bH3 cell line, treated with 0 μM A1CF, 0 μM Cas9 RNPA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM2497EGUQEndoC-βH1 cell line, treated with 0 μM SPOCK2A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM9444BMDZB cell lineTHE HUMAN PANCREAS ANALYSIS PROGRAM FOR TYPE 2 DIABETESreleased
- HumanBetaCellLinesPKBSM6804KICFEndoC-βH1 cell line, treated with 0 μM non-targeting shRNAA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM9024KLYKEndoC-βH1 cell line, treated with 0 μM stromal cellA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM2542NXUUEndoC-βH1 cell line, treated with 0 μM negative control siRNA for 24 hours, 2000 U/mL Interferon alpha for 24 hoursA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM3112HPHHEndoC-bH2 cell line, treated with 20 mM Glucose for 72 hoursA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM6822XTNLEndoC-βH1 cell line, treated with 0 μM STAT3A Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM3992LBEWEndoC-βH1 cell line, treated with 1000 U/mL Interleukin-1 beta for 48 hours, 50 U/mL Interferon gamma for 48 hoursA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
- HumanBetaCellLinesPKBSM1534PVXTEndoC-βH1 cell line, treated with 0 μM negative control siRNA for 72 hoursA Data and Administrative Coordinating Center for the PanKbase Consortium U24DK138512-DK138515released
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
